Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report

Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Klanova, Magdalena, Klener, Pavel, Trneny, Marek, Straub, Jan, Spicka, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207597/
https://www.ncbi.nlm.nih.gov/pubmed/25374735
http://dx.doi.org/10.1155/2012/978479
_version_ 1782340999274561536
author Klanova, Magdalena
Klener, Pavel
Trneny, Marek
Straub, Jan
Spicka, Ivan
author_facet Klanova, Magdalena
Klener, Pavel
Trneny, Marek
Straub, Jan
Spicka, Ivan
author_sort Klanova, Magdalena
collection PubMed
description Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to systemic myeloma progression.
format Online
Article
Text
id pubmed-4207597
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42075972014-11-05 Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report Klanova, Magdalena Klener, Pavel Trneny, Marek Straub, Jan Spicka, Ivan Case Reports Immunol Case Report Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-κ MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed good local response, the patient succumbed due to systemic myeloma progression. Hindawi Publishing Corporation 2012 2012-10-11 /pmc/articles/PMC4207597/ /pubmed/25374735 http://dx.doi.org/10.1155/2012/978479 Text en Copyright © 2012 Magdalena Klanova et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Klanova, Magdalena
Klener, Pavel
Trneny, Marek
Straub, Jan
Spicka, Ivan
Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title_full Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title_fullStr Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title_full_unstemmed Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title_short Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
title_sort intrapleural bortezomib for the therapy of myelomatous pleural effusion: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207597/
https://www.ncbi.nlm.nih.gov/pubmed/25374735
http://dx.doi.org/10.1155/2012/978479
work_keys_str_mv AT klanovamagdalena intrapleuralbortezomibforthetherapyofmyelomatouspleuraleffusionacasereport
AT klenerpavel intrapleuralbortezomibforthetherapyofmyelomatouspleuraleffusionacasereport
AT trnenymarek intrapleuralbortezomibforthetherapyofmyelomatouspleuraleffusionacasereport
AT straubjan intrapleuralbortezomibforthetherapyofmyelomatouspleuraleffusionacasereport
AT spickaivan intrapleuralbortezomibforthetherapyofmyelomatouspleuraleffusionacasereport

Ejemplares similares